seed
Stage
1
Investors
About
STRM.Bio develops engineered stem cell therapies aimed at treating inflammatory diseases and conditions through advanced cell-based therapeutics.
Explore STRM.Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.